Artificial Intelligence driven Marketing Communications
The demand for active pharmaceutical ingredients (APIs) is presently rising across the globe on account of the burgeoning pharmaceutical industry. This growth can primarily be attributed to the increasing expenditure on healthcare facilities, in confluence with the growing investments in the drug development sector. According to the global active pharmaceutical ingredients market reportby IMARC Group, the market reached a value of US$ 176.3 Billion in 2018. Looking forward, the global active pharmaceutical ingredients market size is further projected to reach US$ 247.2 Billion by 2024, at a CAGR of around 5.8% during 2019-2024.
With the growing demand for APIs across the globe, the major top active pharmaceutical ingredients companies are enhancing their manufacturing capabilities as well as engaging in mergers and acquisition activities. In this article, we will be elaborating on some of the major players that are operating in the industry.
1. Pfizer, Inc.
2. Novartis International AG
4. Boehringer Ingelheim
5. Bristol-Myers Squibb
6. Teva Pharmaceutical Industries Ltd.
7. Eli Lilly and Company
9. Merck Co.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.